CLINICAL DRUG INVESTIGATION

由Adis国际有限公司(现在是Wolters Kluwer Health的一部分)出版。ISSN: 1173 - 2563。临床药物调查为您提供了快速访问最佳设计，同行审查的临床和药物经济学研究世界各地，让您跟上最新的原始研究在这个令人兴奋的领域。该杂志的目标是快速出版涵盖临床药物开发和治疗使用的所有阶段的原始研究。这包括临床试验结果的研究,临床pharmacoeconomic研究,药物流行学研究有很强的链接优化处方实践一种药物或一组药物,临床药效学和临床药代动力学研究有很强的联系临床实践,在某些情况下,药效学和药代动力学研究在健康的志愿者,但一些建立或声称对临床处方进行了讨论。此外，还鼓励符合这些标准的简短通信和案例研究报告，以及给编辑的信。

Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1173-2563.Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor.